April Kelly Scott Salama, MD

Associate Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 30 Duke Medicine Circle, 25177 Morris Bldg, Durham, NC 27710
In Their Words

Education and Training

  • Hematology/Oncology, The University of Chicago, 2007 - 2010
  • Internal Medicine, The University of Chicago, 2004 - 2007
  • M.D., University of North Carolina - Chapel Hill, 2004

Grants

Publications

Nathan, Paul, Jessica C. Hassel, Piotr Rutkowski, Jean-Francois Baurain, Marcus O. Butler, Max Schlaak, Ryan J. Sullivan, et al. “Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.” N Engl J Med 385, no. 13 (September 23, 2021): 1196–1206. https://doi.org/10.1056/NEJMoa2103485.

PMID
34551229
Full Text

Dikshit, Anushka, Junqi Lu, Amy E. Ford, Simone Degan, Yingai J. Jin, Huiying Sun, Amanda Nichols, et al. “Potential Utility of Synthetic D-Lactate Polymers in Skin Cancer.” Jid Innovations 1, no. 3 (September 2021): 100043–100043. https://doi.org/10.1016/j.xjidi.2021.100043.

Full Text

Salama, A. K. S., V. Cheshuk, J. Siveke, A. Berrocal, S. E. Abdullah, S. Lockwood, M. L. McCully, and D. Kee. “1014P Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in previously untreated patients with metastatic uveal melanoma.” In Annals of Oncology, 32:S855–S855. Elsevier BV, 2021. https://doi.org/10.1016/j.annonc.2021.08.1398.

Full Text

Sarver, Melissa, Michael C. Brown, Kristen E. Rhodin, April K. S. Salama, and Georgia M. Beasley. “Predictive factors of neoadjuvant immune checkpoint blockade in melanoma.” Hum Vaccin Immunother, July 13, 2021, 1–9. https://doi.org/10.1080/21645515.2021.1943987.

PMID
34254900
Full Text

DeVito, Nicholas C., Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K. S. Salama, Georgia M. Beasley, et al. “Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.” Cell Rep 35, no. 5 (May 4, 2021): 109071. https://doi.org/10.1016/j.celrep.2021.109071.

PMID
33951424
Full Text

Johnson, D. B., S. M. Swetter, A. K. S. Salama, and E. Wuthrick. “Cutaneous melanoma: Management of melanoma brain metastases and molecular testing.” In Jnccn Journal of the National Comprehensive Cancer Network, 19:644–47, 2021. https://doi.org/10.6004/jnccn.2021.5021.

Full Text

Swetter, Susan M., John A. Thompson, Mark R. Albertini, Christopher A. Barker, Joel Baumgartner, Genevieve Boland, Bartosz Chmielowski, et al. “NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.” J Natl Compr Canc Netw 19, no. 4 (April 1, 2021): 364–76. https://doi.org/10.6004/jnccn.2021.0018.

PMID
33845460
Full Text

Beasley, Georgia M., Smita K. Nair, Norma E. Farrow, Karenia Landa, Maria Angelica Selim, Carol Ann Wiggs, Sin-Ho Jung, et al. “Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma.” J Immunother Cancer 9, no. 4 (April 2021). https://doi.org/10.1136/jitc-2020-002203.

PMID
33875611
Full Text

Salama, April K. S., Manisha Palta, Christel N. Rushing, M Angelica Selim, Kristen N. Linney, Brian G. Czito, David S. Yoo, et al. “Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma.” Clin Cancer Res 27, no. 5 (March 1, 2021): 1287–95. https://doi.org/10.1158/1078-0432.CCR-20-2452.

PMID
33172894
Full Text

Patrinely, J Randall, Ben McGuigan, Sunandana Chandra, Sarah E. Fenton, Akansha Chowdhary, Lucy B. Kennedy, Meghan J. Mooradian, et al. “A multicenter characterization of hepatitis associated with immune checkpoint inhibitors.” Oncoimmunology 10, no. 1 (February 8, 2021): 1875639. https://doi.org/10.1080/2162402X.2021.1875639.

PMID
33628621
Full Text

Pages